|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
|Ticker||Company||Price||Change||Chg %||Mkt Cap|
You can purchase shares of Pieris Pharmaceuticals (NASDAQ: PIRS) through any online brokerage.
The latest price target for Pieris Pharmaceuticals (NASDAQ: PIRS) was reported by Baird on 2020-03-13. The analyst firm set a price target for 5.00 expecting PIRS to rise to within 12 months (a possible 159.07% upside). 0 analyst firms have reported ratings in the last year.
The stock price for Pieris Pharmaceuticals (NASDAQ: PIRS) is $1.93 last updated Fri May 07 2021 20:00:01 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Pieris Pharmaceuticals.
There is no upcoming split for Pieris Pharmaceuticals.